– UK, London – Cello Health plc (LON:CLL), the global healthcare focused advisory group, today announced the appointment of Chris Jones as Non-Executive Chairman of the Group with immediate effect, following the retirement of Allan Rich from the Board.
Chris Jones has been a Non-Executive Director of Cello since October 2016. He was formerly Global Chairman and CEO of J Walter Thompson Co based in New York, part of WPP Group plc. Amongst other directorships, Chris is also a director of Becton Dickinson & Co, the major US-based multinational medical technology company.
Mark Scott, Chief Executive, commented: “The Board wishes to wholeheartedly thank Allan Rich for his invaluable contribution to Cello over the years from its inception. Chris knows the group and the healthcare industry well and can help guide the Board through the Group’s next stage of growth and development.”
For more information : http://www.cellohealth.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.